NOVONORM 1 mg Tablets – 30 Tablets
Active Ingredient: Repaglinide 1 mg
Therapeutic Class: Oral Antidiabetic – Meglitinide
Description:
NOVONORM contains repaglinide, a meglitinide class oral antidiabetic that stimulates rapid insulin secretion from pancreatic beta cells. It helps control blood glucose levels in adults with type 2 diabetes, especially to reduce post-meal blood sugar spikes.
Indications:
Treatment of type 2 diabetes mellitus in adults when diet and exercise alone are insufficient.
Can be used alone or with metformin.
Dosage:
Usually taken before meals, 0.5 to 4 mg daily divided into 2-4 doses.
Dose adjusted based on blood glucose monitoring.
Contraindications:
Type 1 diabetes
Diabetic ketoacidosis
Hypersensitivity to repaglinide
Warnings:
Risk of hypoglycemia, especially if meals are missed
Use with caution in liver impairment
Not recommended during pregnancy or breastfeeding
Side Effects:
Hypoglycemia
Headache
Gastrointestinal discomfort
Storage:
Store below 30°C in a dry place away from sunlight.